Juan A. Arnaiz - Concepedia

Author

Juan A. Arnaiz

Also Known As

José M. Gatell, Juan A Arnaiz, Juan A. Arnaiz, Juan A. Schoenenberger Arnaiz, Juan Alberto Arnaiz

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Juan A. Arnaiz is an author at Hospital Clínic de Barcelona specializing in pharmacotherapy, hiv/aids counselling, and virology.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	34
2	Pharmacology	1	1	34
3	Hiv	1	1	34
4	Hiv/aids Counselling	1	1	34
5	Pharmacotherapy	1	1	34

Juan A. Arnaiz

Publications

801

Citations

H-Index

Page 1

	Year	Citations
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy Estebán Martínez, José Luís Blanco, Juan A. Arnaiz, AIDS	2001	351
Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients with Human Immunodeficiency Virus Infection Estebán Martínez, Juan A. Arnaiz, Daniel Podzamczer, New England Journal of Medicine	2003	293
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load Juan A. Arnaiz, Josep Mallolas, Daniel Podzamczer, AIDS	2003	61
Effects of Metformin Or Gemfibrozil on the Lipodystrophy of HIV-Infected Patients Receiving Protease Inhibitors Estebán Martínez, Peré Domingo, Esteban Ribera, Antiviral Therapy	2003	39
Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients Estebán Martínez, Juan A. Arnaiz, Daniel Podzamczer, AIDS Sustained Virological SuppressionHiv/aids CounsellingProtease InhibitorTreatment And PreventionPharmacology	2007	34
Maraviroc, as a Switch Option, in HIV-1–infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study Sarah Pett, Janaki Amin, A Horban, Clinical Infectious Diseases	2016	23

Page 1